Suggestions
Alan Rowan
Director of the Australian Institute for Bioengineering and Nanotechnology
Alan Rowan is the Director of the Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland.146 He took on the role in January 2016.14 Rowan's research focuses on the interaction of cells with nanostructured materials and surfaces.3
Rowan's qualifications include a Bachelor (Honours) of Science (Advanced) and a Doctor of Philosophy from the University of Liverpool.2 He received a first-class honors degree in chemistry and was awarded the Leverlhulme Medal.14 His PhD work involved the self-assembly of chlorophylls.14 He then spent two years in New Zealand researching catenane and rotaxane self-assembly with Professor Chris Hunter.14 As a Marie-Curie Fellow, he worked with Professor Roeland Nolte in the Netherlands, studying functional supramolecular assemblies.14 In 2005, he became a full professor in Nijmegen, establishing a group focused on molecular materials and the relationship between molecular assembly and functional properties.14
Professor Rowan has made significant contributions to the fields of chemistry and biology, particularly in processive catalysis and functional self-assembly.145 More recently, he developed a biomimetic hydrogel that mimics the mechanical and functional properties of the extracellular membrane.14
Rowan has published nearly 300 peer-reviewed articles and books, including 18 in the Science and Nature family of journals.34 His work has been cited over 17,000 times and has led to several patents with commercial applications.3 He has also supervised more than 55 PhD students.13
In 2013, Rowan was a nominee for Netherlands Science Entrepreneur of the Year.13 He has been granted five patents and has five pending in the area of nanomedicine.3 Rowan has been involved in the startup of four companies: Encapson, Noviotech, NovioSense, and Secmatix.13
Alan Rowan was elected as a Fellow of the Australian Academy of Science in 2020.7

